Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) EBT Margin (2020 - 2025)

Celularity has reported EBT Margin over the past 6 years, most recently at 436.71% for Q3 2025.

  • Quarterly results put EBT Margin at 436.71% for Q3 2025, down 26354.0% from a year ago — trailing twelve months through Sep 2025 was 348.61% (down 27591.0% YoY), and the annual figure for FY2024 was 106.77%, up 75522.0%.
  • EBT Margin for Q3 2025 was 436.71% at Celularity, down from 427.55% in the prior quarter.
  • Over the last five years, EBT Margin for CELU hit a ceiling of 1267.03% in Q2 2022 and a floor of 3065.38% in Q1 2021.
  • Median EBT Margin over the past 5 years was 173.17% (2024), compared with a mean of 672.89%.
  • Biggest five-year swings in EBT Margin: surged 328383bps in 2022 and later plummeted -289906bps in 2023.
  • Celularity's EBT Margin stood at 82.78% in 2021, then soared by 815bps to 592.08% in 2022, then tumbled by -87bps to 78.91% in 2023, then tumbled by -2549bps to 1932.12% in 2024, then skyrocketed by 77bps to 436.71% in 2025.
  • The last three reported values for EBT Margin were 436.71% (Q3 2025), 427.55% (Q2 2025), and 172.89% (Q1 2025) per Business Quant data.